Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

Trends in Microbial Testing and Antibiotic Resistance Detection

New article in The Pathologist reports on shifting clinical needs

Molecular diagnostics will be a critical part of microbial testing, especially in the battle against antibiotic resistance, according to a recent article in The Pathologist from Luminex’s own Sherry Dunbar, Sr. Director of Global Scientific Affairs, and Gunjot Rana, Product Manager for Gastrointestinal and Hospital Acquired Infections.

Continue Reading >

Galapagos, A Luminex Partner

Galapagos, A Luminex Partner


The team from Galapagos NV talks about their Mission to become the largest Biotech company in Europe, and how automating the Luminex FLEXMAP 3D® system is helping with their drug discovery.

Watch more videos >

Luminex on Twitter

It’s the last day of #KMIS2017. If you haven’t had the chance, be sure to stop by to learn about our portfolio of s…
h J R
Be sure to visit our booth at #KMIS2017 to learn about our targeted and syndromic solutions for your testing needs.…
h J R
We are just getting started at #xMAPConnect in Beijing. Thank you to APAC General Manager, Andrew Cheung, for intro…
h J R

Latest News

November 14
Luminex Corporation To Present At The 29th Annual Piper Jaffray Healthcare Conference

October 31
Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay

October 30
Luminex Corporation Reports Third Quarter 2017 Financial Results

October 9
Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017

September 19
Luminex Corporation To Present At Cantor Fitzgerald’s Global Healthcare Conference

September 12
Luminex Corporation Declares Third Quarter Cash Dividend


SWACM Annual Meeting
September 6-9
St. Louis, MO

xMAP Connect U.S. 2017
September 19
Boston, MA

Intermountain States Seminar
September 29-30
Jackson, WY

PSI Annual Meeting
October 3
Dublin, OH

October 4-8
San Diego, CA